Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Living with scleroderma].

Jean Cabane1

  • 1Service de médecine interne Hôpital Saint-Antoine 75571 Paris. jean.cabane@sat.ap-hop-paris.fr

La Revue Du Praticien
|January 21, 2003
PubMed
Summary
This summary is machine-generated.

Living with scleroderma presents significant challenges due to its painful and incapacitating effects. Effective management requires integrating various aids, patient support, and non-pharmaceutical treatments alongside medical care.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient acceptable symptom state and minimal clinically important difference for patient-reported outcomes in systemic sclerosis: A secondary analysis of a randomized controlled trial comparing personalized physical therapy to usual care.

Seminars in arthritis and rheumatism·2018
Same author

High Baseline Serum Clara Cell 16 kDa Predicts Subsequent Lung Disease Worsening in Systemic Sclerosis.

The Journal of rheumatology·2017
Same author

Comparing Inpatient Satisfaction Collected via a Web-Based Questionnaire Self-Completion and Through a Telephone Interview: An Ancillary Study of the SENTIPAT Randomized Controlled Trial.

Journal of medical Internet research·2017
Same author

Personalized Physical Therapy Versus Usual Care for Patients With Systemic Sclerosis: A Randomized Controlled Trial.

Arthritis care & research·2016
Same author

Anti-Ephrin Type-B Receptor 2 (EphB2) and Anti-Three Prime Histone mRNA EXonuclease 1 (THEX1) Autoantibodies in Scleroderma and Lupus.

PloS one·2016
Same author

Granulomatosis with polyangiitis: endoscopic management of tracheobronchial stenosis: results from a multicentre experience.

Rheumatology (Oxford, England)·2015
Same journal

[Prolonged fever].

La Revue du praticien·2026
Same journal

[Lower gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[Management of antiplatelet agents and oral anticoagulants in cases of gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[A history of child abuse intervention in the West].

La Revue du praticien·2026
Same journal

[Agranulocytose médicamenteuse].

La Revue du praticien·2026
Same journal

[Patient education in heart failure].

La Revue du praticien·2026
See all related articles

Area of Science:

  • Rheumatology and Immunology
  • Patient-Reported Outcomes
  • Quality of Life Research

Context:

  • Scleroderma, a chronic autoimmune disease, imposes a substantial burden on patients and families.
  • The disease's lengthy progression, uncertain prognosis, and functional limitations create complex challenges.
  • Managing scleroderma requires a multifaceted approach beyond conventional medical interventions.

Purpose:

  • To highlight the difficulties of living with scleroderma.
  • To emphasize the need for a comprehensive strategy in managing the disease's consequences.
  • To underscore the importance of integrating various supportive measures for improved patient outcomes.

Summary:

  • Scleroderma significantly impacts daily life, causing pain and functional impairment.

Related Experiment Videos

  • Patients face a heavy burden due to the disease's chronic nature and unpredictable course.
  • Optimal management involves combining medical treatments with life aids, patient associations, and non-pharmaceutical therapies.

    • Impact:

    • Improved quality of life for scleroderma patients.
    • Better integration of supportive care alongside medical management.
    • Empowerment of patients and families through comprehensive support systems.